Previous 10 | Next 10 |
home / stock / nvo / nvo articles
Novo Nordisk A/S (NYSE: NVO) announced topline results from the COMBINE 3 phase 3a trial of once-weekly IcoSema, a fixed-ratio combi...
On Friday, a comprehensive U.S. study revealed that the use of Novo Nordisk A/S's (MYSE: NVO) drugs Ozempic and Wegovy, widely prescr...
Drugmaker Eli Lilly And Co (NYSE:LLY) announced on Thursday a new website that allows patients to get a weight loss drug prescription through a...
As another holiday season fades into memory, and we return to our desks — perhaps a little flabbier and a little hungover — will investors thin...
Novo Nordisk A/S (NYSE:NVO), the maker of ‘Miracle‘ weight loss drugs Ozempic and Wegovy, is reportedly set to construct a large-scale ...
The FDA on Thursday said it continues to investigate counterfeit Novo Nordisk A/S's (NYSE: NVO) Ozempic (semaglutide) injec...
Novo Nordisk (NYSE:NVO) has outperformed the market over the past 10 years by 9.16% on an annualized basis producing an average annual return of 19...
Nestle S.A. (OTC: NSRGY) CEO Mark Schneider stated that despite the rising use of weight loss medications like Eli Lilly And Company'...
IndiaMART, an online marketplace in India, has reportedly taken action to remove unauthorized listings of Novo Nordisk A/S's (NYSE: N...
News, Short Squeeze, Breakout and More Instantly...
2024-07-23 05:48:00 ET Novo Nordisk (NYSE: NVO) is riding the Ozempic/Wegovy train straight to the bank. Eli Lilly (NYSE: LLY) is doing the same with Mounjaro and Zepbound. Both big drugmakers have multibillion-dollar obesity drug franchises that continue to grow rapidly. Sh...
2024-07-17 13:21:54 ET Shares of Swiss pharmaceuticals company Roche Holding (OTC: RHHBY) soared 7% through 11:55 a.m. ET Wednesday on positive data from phase 1 clinical trials of its new weight loss drug CT-996. But good news for Roche is bad news for the companies that no...
2024-07-14 05:20:00 ET Two pharma juggernauts, Novo Nordisk (NYSE: NVO) and Eli Lilly (NYSE: LLY) , are picking up speed in their preparations for an epic battle to control the market for weight loss drugs. The prize for the victor will be a larger market share of what may b...